Form 8-K Satsuma Pharmaceuticals, For: Jun 06

Form 8-K Satsuma Pharmaceuticals, For: Jun 06

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Delaware , United States , State Of Delaware , Japan , Washington , American , Japanese , Nippon , Shunji Haruta , Heath Lukatch , Shuichi Kanazashi , Michael Riebe , Tom Soloway , Shinji Nitanda , Akihisa Mori , Ryoichi Nagata , Rajeev Shah , Mutya Harsch , Ken Takanashi , John Kollins , Thomasb King , Securities Exchange , Company Current Report On Form , Virtu Americas , Company On , Satsuma Pharmaceuticals Inc , Shin Nippon Biomedical Laboratories Ltd , Exchange Commission On , Merger Sub Inc , Merger The Surviving Corporation , Company The Merger , Corporation Law Of The State Delaware , Nasdaq , Securities Exchange Act , Zip Code , Securities Act , Exchange Act , Current Report , Satsuma Pharmaceuticals , Shin Nippon Biomedical Laboratories , Merger Sub , Material Definitive Agreement , Incentive Plan , Award Plan , Stock Purchase , At The Market Sales Agreement , Sales Agreement , Exchange Commission , Merger Agreement , Stock Transfer , Trust Company , Guaranteed Delivery , General Corporation Law , American Stock Transfer , Offer Price , Effective Time , Company Option , Continued Listing Rule , Nasdaq Stock Market , Security Holders , Introductory Note , Certain Officers , Compensatory Arrangements , Elisabeth Sandoval Little , Chief Executive Officer , Chief Financial Officer , Fiscal Year , Restated Certificate , Restated Bylaws , Fifth Amended , Page Interactive Data File ,

comparemela.com © 2020. All Rights Reserved.